Ford recalls 456,000 Broncos, Mavericks that may lose power, raising crash risks The automaker is recalling Bronco Sport and Maverick vehicles due to a battery detection issue that can result in loss of drive power, increasing crash risks. The Associated Press
Persistent shortage of growth hormone frustrates parents and clinicians As a shortage of growth hormone used to treat rare diseases in children drags on, families and doctors are struggling with insurers' requirements to get prescriptions filled. Sydney Lupkin
World Despite global instability, IMF says world economy show 'remarkable resilience' NPR's Leila Fadel talks to Pierre-Olivier Gourinchas, chief economist at the International Monetary Fund, about the health of the global economy.
World Biden wants to hike tariffs on imports of Chinese steel and aluminum The White House says China uses subsidies and government programs to undercut U.S. steel. President Biden wants to triple tariffs on the imports and take other new steps to curb imports. Asma Khalid
Why this vote at a Tennessee Volkswagen plant is historic for the South Volkswagen workers in Chattanooga, Tenn., are voting this week on whether to join the United Auto Workers union. Two previous attempts to unionize the plant failed. Ballots will be counted on Friday. Stephan Bisaha Andrea Hsu
What's behind Molbak's return as the 'Green Phoenix Collaborative' What is the "Green Phoenix Collaborative?" John O'Brien Dyer Oxley
Tesla announces it's laying off more than 10% of its global workforce NPR's Michel Martin speaks with journalist Jameson Dow at Electrek about what's behind the layoffs at Tesla.
Rise and grind? Working late, volatile hours may lead to depression, illness by 50 Burnt out much? A study links working late, or variable shifts with health problems later in life. Maybe it's time to quit hustle culture for good. Ronnie Cohen
Truth Social shares tumble again. It's making for an incredibly volatile ride Trump Media & Technology Group fell sharply after saying it was issuing new shares. Trump's stake is still worth billions of dollars, however. Rafael Nam
Drugmakers' low U.S. taxes belie their high sales Most of the largest pharmaceutical companies report losing money in the United States, despite the majority of their sales coming from Americans. The result is lower U.S. taxes for the companies. Sydney Lupkin